A COMPARATIVE STUDY REGARDING THE SOCIO-ECONOMIC IMPACT OF OSTEOARTHRITIS ON PEOPLE AND THE IMPORTANCE OF EARLY DIAGNOSIS
Corresponding author:
[email protected]
Accepted
27 March 2026
Available Online
15 March 2015
Abstract
THIS ARTICLE INTENDS TO UNDERLINE THE ECONOMIC IMPORTANCE OF OSTEOARTHRITIS IN THE WORLD, FOUNDING ITSELF ON INFORMATION THAT WAS PUBLISHED REGARDING THE COSTS OF THIS DISEASE FOR PATIENTS AND GOVERNMENTS. OSTEOARTHRITIS DOESN’T ONLY AFFECT THE BUDGETS OF HEALTH SERVICES, BUT ALSO OF SOCIETY AS A WHOLE, THROUGH ITS IMPACT ON SICK PEOPLE, ON THE EMPLOYERS, ETC. IN THE CASE OF ACTIVE PATIENTS, THE INDIRECT COSTS ARE MUCH HIGHER, COMPARED TO THE DIRECT ONES. STUDIES CONCERNING THE COSTS OF THIS DISEASE IN DIFF ERENT COUNTRIES ARE NOT COMPARABLE IN A DIRECT WAY, BECAUSE OF THE DIFFERENT APPROACHES, THE DEMOGRAPHIC CHANGES, AND THE CHARACTERISTICS OF THE HEALTH INSURANCE SYSTEM. DEVELOPING THE MOST EFFICIENT TREATMENTS, EARLY DIAGNOSIS AND PREVENTING THE DISEASE R EPRESENT IMPORTANT STEPS IN ORDER TO DIMINISH THE CLINICAL AND ECONOMIC EFFECTS THAT THIS DISEASE CAUSES ALL OVER THE WORLD.
Keywords
OSTEOARTHRITIS
COSTS
EPIDEMIOLOGY
PREVALENT
INCIDENCE
Full Text
The body of this article is intentionally hidden on the public page. Please use the PDF reader or the PDF download for the complete text.
References
[1]
Curtis, Lesley. Unit Costs of Health and Social Care 2009 . UK.: Personal Social Services Research Unit, The University of Kent, 2010. Article in a print journal
[2]
Altman R and Asch E and Bloch D and Bole G and Borenstein D and Brandt K , et al. „ Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Commitee of American Rheumatism Association.” Arthritis and Rheumatism 29 (1986): 1039-49.
[3]
Anderson JJ and Felson DT . „ Factors associated with osteoarthritis of knee in the first national Health and Nu trition Examination Survey (HANES I). Evidence for an association with overweight, race, and physical demands of work.” American Journal of Epidemiology 128 (1988): 179-89.
[4]
Felson DT et al. “Osteoarthitis: New Insights.” Annals of Internal Medicine 133 (2000): 635-46.
[5]
Gabriel SE and Crowson CS and Campion ME and Ofallon WM . „Direct medical costs unique to people with arthritis.” Journal of Rheumatology 24 (1997): 719-25.
[6]
Gupta S and Hawker GA and Laporte A and Croxford R and Coyte PC . „ The economi c burden of disabling hip and knee osteoarthritis from the perspective of individuals living with this condition.” Rheumatology, vol. 44, no.12 (2005): 1531-37.
[7]
Helmick CG and Felson DT and Lawrence RC , et al. „Estimates of prevalence of arthritis and othe r rheumatic conditions in the United States.” Arthritis and Rheumatology, Part I, 58 (2008): 15-25.
[8]
Hermans J and Koopmanschap MA and Bierma -Zeinstra SMA, et al. „Productivity costs and medical costs among working patients with knee osteoarthritis.” Arthritis Care and Research , 64 (2012): 853 - 61.
[9]
Kazis LE and Meenan RF and Anderson JJ . „Pain in the rheumatic diseases. Investigation of a key health status component.” Arthritis and Rheumatology, 26 (1983): 1017-22.
[10]
Kellgren JH and Lawrence JS. „Osteoarthritis and disk degeneration in an urban population.” Annals of Rheumatic Diseases, 17 (1958): 388-97.
[11]
Kotlarz H and Gunnarsson CL and Fang H, and Rizzo JA . „Osteoarthritis and absenteeism costs: evidence from US national survey data.” Journal of Occupational an d Environmental Medicine , vol. 52, no. 3 (2010): 263-68.
[12]
Leardini G and Salaffi F and Caporali R , et al. „Direct and indirect costs of osteoarthritis of the knee.” Clinical Experimental Rheumatology, 22 (2004): 699-706.
[13]
Le Pen C and Reygrobellet C, Gerente s I. „Financial cost of osteoarthritis in France. The „COART” France study.” Joint Bone Spine, 72 (2005): 567-70.
[14]
Loza E and Lopez -Gomez JM, Abasolo L , et al. „Economic burden of knee and hip osteoarthritis in Spain.” Arthritis Rheumatology, 61 (2009): 158-65.
[15]
March LM and Bachmeier CJM. „Economics of osteoarthritis: a global perspective.” Bailliere’s Clinical Rheumatology, vol. 11, no. 4, (1997): 817-34.
[16]
Moore R and Phillips C . „Cost of NSAID adverse effects to the UK National Health Service.” Journal Medical Economy, 2 (1999): 45-55.
[17]
Murray CJL and Lopez AD . „Global mortality, disability, and the contribution of risk factors: global burden of disease study.” The Lancet, vol. 349, no. 9063, (1997), 1436-42.
[18]
Rabenda V and Manette C and Lemmens R et al. „D irect and indirect costs attributable to osteoarthritis in active subjects.” Journal of Rheumatology, 33(6), (2006), 1152-58.
[19]
Sabariego C and Brach M and Stucki G. „Determinants of major direct medical cost categories among patients with osteoporosis, oste oarthritis, back pain or fibromyalgia undergoing outpatient rehabilitation.” Journal of Rehabilitation Medical 43 (2011): 703-8.
[20]
Segel J „Cost-of-Illness Studies – A Primer.” RTI-UNC Center of Excellence in Health Promotion Economics (2006).
[21]
Tarride JE and Haq M and O’Reilly DJ , et al. „The excess burden of osteoarthritis of knee in the first national Health and Nutrition Examination Survey (HANES I). Evidence for an association with overweight, race, and physical demands of work.” American Journal of Epide miology, 128 (1998): 179-189.
[22]
Van Baar ME and Dekker J and Lemmens JA and Oostendorp RA and Bijlsma JW . „ Pain and disability in patiens with osteoarthritis of hip or knee: the relationship with articular, kinesiological, and psychological characteristics.” Journal of Rheumatology, 25 (1998): 125-133. Research and Science Today No. 1(9)/2015
[23]
Woolf AD and Pfleger B. „Burden of major musculoskeletal conditions.” Bulletin of the World Health Organization, vol. 81, no. 9, (2003), 646-56.
[24]
Xie F and Thumboo J and Fong KY et al. „ A study on indirect and intangible costs for patients with knee osteoarthritis in Singapore.” Value in Health, vol. 11, no. 1, (2008), 84-90.